Fact-checked by Grok 2 weeks ago

Seizure threshold

The seizure threshold refers to the minimum intensity of stimulus or degree of imbalance in neuronal activity required to trigger a , representing an individual's inherent susceptibility to abnormal electrical discharges in the . This threshold exists on a continuum for everyone, influenced by the balance between excitatory (e.g., ) and inhibitory (e.g., ) forces in the , where a lower increases the likelihood of seizures occurring under certain conditions. Individuals with typically have a genetically or pathologically lowered seizure threshold, making recurrent, unprovoked seizures more probable compared to the general population, whose higher thresholds protect against such events unless provoked by acute factors. Key factors that can lower the seizure threshold include genetic predispositions, such as family history of epilepsy; physiological states like sleep deprivation, stress, or hormonal fluctuations (e.g., during menstruation); and environmental triggers such as flashing lights, fever, or high temperatures. Certain medications, including some antidepressants, antipsychotics, opioids, and even over-the-counter drugs like high-dose aspirin, can also reduce the threshold, while antiepileptic drugs work primarily by raising it to prevent seizures. Conversely, elements like adequate sleep, stress management, and consistent medication adherence can help maintain or elevate the threshold, underscoring the importance of personalized epilepsy management strategies. In clinical contexts, understanding an individual's seizure threshold guides treatment decisions, such as electroconvulsive therapy dosing or risk assessment for seizure-provoking procedures, emphasizing its role in neurology and epileptology.

Definition and Basic Concepts

Definition

The seizure threshold refers to the minimum of an electrical, chemical, or physiological stimulus required to provoke a in a susceptible . This concept encapsulates the brain's inherent resistance to excessive neuronal firing, where stimuli below the threshold fail to disrupt normal activity, while those at or above it can initiate synchronized, abnormal discharges characteristic of a . Individuals vary along a continuum of susceptibility, ranging from high thresholds in those with robust resistance to low thresholds in populations prone to recurrent s, such as people with . In , this lowered threshold reflects an underlying predisposition that makes s more likely under otherwise subthreshold conditions, distinguishing it from isolated, provoked events in non-epileptic individuals. It was first systematically quantified in animal models during , notably through electroshock experiments by Merritt and Putnam, who used controlled stimuli in and dogs to measure the precise electrical intensity needed to induce seizures, laying the groundwork for drug screening.

The seizure represents an individual's susceptibility to developing seizures, positioned on a influenced by various factors, where a lower heightens the of spontaneous, unprovoked seizures. This increased susceptibility can lead to recurrent epileptic events, profoundly impacting by causing limitations in daily functioning, employment opportunities, and psychological well-being due to fear of seizure occurrence. Furthermore, a lowered contributes to higher seizure frequency, which is a major factor for (SUDEP), with patients experiencing generalized tonic-clonic seizures three or more times per year facing up to 15-fold elevated SUDEP compared to those without such seizures. In diagnostics, the seizure threshold concept aids in distinguishing epilepsy—a marked by a persistently lowered and recurrent unprovoked seizures—from acute provoked seizures, where transient factors like metabolic disturbances temporarily reduce the without underlying chronic vulnerability. It also informs in neurological disorders; for instance, individuals with a history of insults or early-life exhibit a reduced , predicting accelerated epileptogenesis and higher comorbidity rates, such as cognitive deficits or . Therapeutically, assessing seizure threshold guides decisions to mitigate unintended seizures, particularly when prescribing psychotropic medications known to lower the threshold, such as certain antidepressants or antipsychotics, thereby preventing in susceptible patients. In controlled clinical contexts, this understanding ensures appropriate dosing or interventions to either avoid crossing the threshold or achieve targeted induction for therapeutic benefit, optimizing patient safety and outcomes.

Physiological Basis

Neuronal Mechanisms

The seizure threshold at the neuronal level is fundamentally governed by the balance between excitatory and inhibitory synaptic . Excitatory , primarily mediated by glutamate acting on ionotropic receptors such as NMDA and receptors, depolarizes the neuronal membrane by allowing influx of cations like Na⁺ and Ca²⁺, thereby promoting generation. In contrast, inhibitory via , predominantly through GABA_A receptors, hyperpolarizes the membrane by Cl⁻ influx, counteracting excitatory drive and stabilizing the . Disruptions in this excitatory-inhibitory (E/I) balance, such as excessive glutamate release or diminished inhibition, lower the seizure threshold by facilitating easier to firing levels. Hyperexcitability contributing to a reduced seizure threshold often arises from dysfunction, particularly in voltage-gated sodium channels (VGSCs). Mutations in genes encoding VGSC α-subunits, such as SCN1A, SCN2A, and SCN8A, can lead to gain-of-function effects, including persistent sodium currents that prolong and increase neuronal firing rates. For instance, these mutations impair channel inactivation, resulting in sustained inward currents that lower the energy required for initiation and promote burst firing. Such channelopathies are implicated in various epilepsies, where they disrupt normal and enhance overall membrane excitability. Synaptic plasticity mechanisms further modulate the seizure threshold by altering synaptic strength in favor of excitation. Activity-dependent changes, such as (LTP) at glutamatergic synapses, strengthen AMPA receptor-mediated transmission, reducing the activation threshold for postsynaptic action potentials. Conversely, impaired plasticity in inhibitory synapses, including downregulation of GABA_A receptor expression, weakens restraint on excitatory networks, thereby lowering the overall threshold for seizure initiation. These plasticity shifts create a pro-epileptogenic environment at the single-neuron level. A simplified conceptual model of neuronal seizure onset illustrates this interplay through membrane potential dynamics. Seizure-like activity emerges when the net excitatory current exceeds inhibitory opposition, such that the change in membrane potential ΔV = I_{excit} - I_{inhib} surpasses the action potential threshold V_{th}, typically around -55 mV relative to a resting potential of -70 mV. \Delta V = I_{\text{excit}} - I_{\text{inhib}} > V_{\text{th}} \quad (\text{where } V_{\text{th}} \approx -55 \, \text{mV})

Network Dynamics

The seizure threshold is significantly influenced by hypersynchronization, a state in which large populations of neurons discharge in unison, particularly in the and . This phenomenon occurs when neuronal ensembles engage in high-frequency bursts exceeding 100 Hz, such as fast ripples (250–500 Hz) and ripples (80–250 Hz), which reflect pathological beyond physiological sharp-wave ripples. Such hypersynchronous activity amplifies excitatory signaling through paroxysmal depolarizing shifts across small cortical networks, thereby lowering the for ictal onset by facilitating the of additional neurons into the discharging population. In epileptic tissue, this is often aperiodic and local, contrasting with the coordinated, transient nature of normal high-frequency oscillations, and it can propagate to encompass extended cortical areas during seizures. Propagation of seizure activity beyond initial local foci relies on interconnected brain networks, particularly thalamocortical circuits and limbic structures like the . Thalamocortical loops, involving reciprocal projections between thalamic nuclei (e.g., centromedian and mediodorsal) and cortical regions, enable rapid dissemination of hypersynchronous discharges from origins to contralateral hemispheres, promoting focal-to-bilateral tonic-clonic seizures. The acts as a hub for , enhancing interregional through increased and in epileptic networks, which facilitates the spread of ictal wavefronts. Similarly, limbic pathways, including the 's projections to the , , and neocortical areas, contribute to propagation by relaying amygdala-kindled activity via strengthened frontotemporal links and thalamic relays, allowing seizures to evolve from limbic motor patterns to widespread cortical involvement. Seizure termination is mediated by intrinsic network feedback mechanisms that restore balance and elevate the post-ictally, preventing prolonged ictal states. A key process is the (AHP), particularly the slow AHP (sAHP), which follows bursts of neuronal firing and induces prolonged membrane hyperpolarization (lasting 1–2 seconds) via calcium-activated potassium channels. This hyperpolarization reduces neuronal excitability across synchronized populations in the and , creating an inhibitory window that desynchronizes networks and limits further propagation by suppressing generation. In epileptic models, sAHP interacts with GABA_B receptor-mediated inhibition to provide , effectively raising the seizure during post-seizure recovery and contributing to the finite duration of most ictal events.

Factors Modulating Seizure Threshold

Endogenous Factors

Endogenous factors refer to intrinsic biological elements that modulate an individual's seizure threshold, influencing neuronal excitability without external influences. Genetic variations play a primary role, particularly mutations in genes that disrupt normal membrane potentials and increase seizure susceptibility. Mutations in the SCN1A , which encodes the Nav1.1 voltage-gated , are a leading cause of genetic epilepsies such as . These loss-of-function mutations predominantly affect , reducing sodium currents by approximately 50% compared to wild-type, thereby lowering the seizure threshold and promoting hyperexcitability. Similarly, mutations in the KCNQ2 , encoding a subunit responsible for the M-current that stabilizes neuronal firing, reduce current amplitude by 20-40% in affected models, resulting in decreased seizure thresholds and early-onset neonatal seizures in syndromes like benign familial neonatal epilepsy or epileptic encephalopathies. Carriers of these mutations exhibit a markedly heightened of spontaneous seizures due to impaired . Age significantly influences seizure threshold, generally increasing it in adulthood, particularly in contexts like (ECT) where physiological changes such as increased volume due to brain are associated with higher thresholds required to induce seizures. However, in the general population, age-related brain and other structural changes can contribute to increased risk after age 60 due to comorbidities and lesions, despite potential rises in intrinsic threshold. Sex differences also contribute, with males typically displaying higher thresholds than females, potentially linked to baseline hormonal profiles. Females experience cyclical variations, where exerts proconvulsant effects by enhancing excitability and lowering the threshold, while progesterone acts as an , elevating it during phases like the luteal period. Hormonal states during can transiently lower the seizure through surges in and other sex steroids, often coinciding with onset in susceptible individuals. Metabolic conditions, such as uncontrolled , further modulate via glucose imbalances; reduces it by altering neuronal energy homeostasis and increasing metabolism, heightening seizure risk. Electrolyte disturbances, including from endocrine disorders, similarly decrease by destabilizing potentials and promoting neuronal firing.

Exogenous Factors

Exogenous factors refer to external influences that can transiently alter the , often by disrupting neuronal excitability or inhibitory mechanisms. These modifiable elements include lifestyle-related triggers, pharmacological agents, and environmental insults, which may lower the threshold in susceptible individuals, increasing seizure risk. Unlike endogenous factors, which are more stable and internal, exogenous ones can be mitigated through behavioral changes or medical interventions. Lifestyle triggers such as significantly lower the seizure threshold by increasing cortical excitability and reducing inhibitory processes. Sleep deprivation promotes seizures and interictal epileptiform discharges, potentially through diminished GABA-mediated tonic inhibition, which facilitates neuronal hyperexcitability. Similarly, acute elevates levels, which hypersecretion decreases the seizure threshold, particularly in , by altering modulation and promoting . Alcohol disrupts signaling, leading to hyperexcitability and a lowered seizure threshold, often manifesting as generalized tonic-clonic seizures within 6-48 hours of cessation. Certain pharmacological agents act as proconvulsants by enhancing monoaminergic activity, thereby reducing the seizure threshold. For instance, bupropion, a norepinephrine-dopamine , lowers the seizure threshold in a dose-dependent manner, with risks increasing at higher doses due to its effects on excitatory . , which inhibits serotonin and norepinephrine alongside opioid , is associated with seizures, particularly in overdose, through monoamine-mediated hyperexcitability. In contrast, anticonvulsants like raise the seizure threshold by enhancing inhibition and modulating voltage-gated ion channels, providing therapeutic protection against seizures. Environmental insults further contribute to threshold modulation via physiological disruptions. Fever and infections lower the seizure threshold through cytokine release, such as IL-1β and IL-6, which enhance neuronal excitability and promote in the . In , exposure to flashing lights or flickering patterns can provoke seizures by inducing epileptiform activity, with maximal risk at frequencies of 10-25 Hz due to reduced inhibition in visual processing networks. Electrolyte disturbances, notably , acutely lower the seizure threshold by causing and neuronal swelling, often triggering generalized seizures when serum sodium falls below 115 mEq/L.

Clinical Applications

In Epilepsy Management

In epilepsy management, assessing the seizure threshold is essential for accurate , particularly in distinguishing epileptic seizures from nonepileptic events. Video-electroencephalography (video-EEG) , often incorporating provocation techniques such as , intermittent photic stimulation, or , can elicit epileptiform discharges that indicate a reduced seizure threshold, supporting of . These methods are particularly valuable in cases where routine EEGs are inconclusive, as they increase the likelihood of capturing ictal activity and clarifying the epileptic nature of events. Treatment strategies in epilepsy focus on optimizing the seizure threshold to minimize seizure occurrence. Antiepileptic drugs (AEDs), such as , elevate the threshold by stabilizing neuronal membranes and reducing hyperexcitability, with studies demonstrating significant increases in the current required to provoke seizures in experimental models. For instance, effectively raises the threshold more prominently in cortical regions compared to subcortical areas like the . In drug-resistant cases, (VNS) provides long-term modulation of the seizure threshold by altering cortical excitability, often resulting in sustained reductions in seizure frequency over years of therapy. Patient education emphasizes maintaining a higher seizure threshold through modifications and trigger avoidance, which empowers individuals to proactively manage their condition. Common , such as , can lower the threshold and precipitate , so advising patients to prioritize consistent and identify personal precipitants—via seizure diaries—helps mitigate risks. In responsive individuals, such strategies can substantially decrease seizure frequency by interrupting potential cascades of hyperexcitability.

In Electroconvulsive Therapy

In (ECT), the seizure threshold plays a crucial role in balancing therapeutic efficacy and minimizing adverse effects when treating severe psychiatric disorders such as major . Determining the individual patient's seizure threshold during the initial session allows clinicians to tailor stimulus intensity, ensuring a generalized of adequate quality while avoiding excessive dosing that could heighten cognitive side effects. This personalized approach enhances the and of ECT by accounting for interpatient variability influenced by factors like , , and electrode placement. Threshold determination typically employs a dose method in the first session, beginning with a low stimulus charge of 20-50 millicoulombs (mC) and incrementally increasing until a generalized is elicited, defined as at least 15 seconds of motor (measured via cuff technique) and 25 seconds of electroencephalographic (EEG) activity. This process identifies the minimal electrical charge required to provoke a therapeutic , guiding subsequent dosing to multiples of this for optimal outcomes. Once established, adjustments to parameters, such as placement, can further modulate the ; bilateral ECT elevates it approximately twofold compared to right unilateral placement, necessitating higher absolute doses for equivalent despite the increased . In cases of high seizure threshold or inadequate seizure quality, pharmacological augmentation with agents like can lower the threshold (e.g., by approximately 35%), facilitating elicitation at reduced electrical intensities and improving for patients. Recent studies as of 2025 indicate that intravenous safely enhances quality and length without increasing adverse effects. Delivering stimuli at 2-6 times the threshold has been shown to enhance response rates, with higher multiples particularly beneficial for unilateral ECT to achieve comparable to bilateral approaches. Over the course of an ECT series, the threshold can rise substantially, often by 20-50% or more due to adaptive neuroplastic changes, such as enhanced neuronal and altered network excitability, requiring progressive increases in stimulus dose to maintain adequacy.

In Pharmacology

In pharmacology, the seizure threshold serves as a critical parameter for evaluating the or proconvulsant properties of drugs, influencing their selection, dosing, and development to mitigate convulsive risks. drugs, such as , elevate the seizure threshold primarily through blockade of voltage-gated sodium channels, which stabilizes neuronal membranes and reduces the propensity for hyperexcitable firing that initiates seizures. Other classes, including benzodiazepines and , achieve similar effects by enhancing inhibitory via gamma-aminobutyric acid ()-A receptor potentiation, thereby increasing the electrical stimulus required to provoke a seizure. In contrast, proconvulsant agents like certain fluoroquinolone antibiotics (e.g., and ) lower the seizure threshold by antagonizing -A receptors, which diminishes inhibitory signaling and heightens neuronal excitability, potentially precipitating seizures even at therapeutic doses. Preclinical safety screening for potential anticonvulsants routinely employs the maximal electroshock () model in to quantify a drug's ability to raise the threshold. In this paradigm, an electrical stimulus is applied via corneal or auricular electrodes to induce tonic hindlimb extension, mimicking generalized tonic-clonic seizures; the effective dose 50 (ED50)—the dose protecting 50% of subjects from seizure manifestation—is calculated to assess potency, with lower ED50 values indicating stronger threshold elevation. For instance, established anticonvulsants like exhibit MES ED50 values around 10-20 mg/kg in mice, providing a for novel compounds during early . This model prioritizes drugs effective against focal and generalized seizures, guiding lead optimization to favor those with broad-spectrum threshold-raising efficacy while minimizing . Clinical guidelines emphasize avoiding or cautiously using proconvulsant drugs in patients with to prevent breakthrough s, recommending alternatives with neutral or elevating effects on the threshold. For example, is contraindicated in those with a seizure history due to its inherent proconvulsant potential via and serotonin/norepinephrine reuptake inhibition, and its coadministration with selective serotonin reuptake inhibitors (SSRIs) further amplifies this risk by 2- to 6-fold through synergistic effects and reduced seizure inhibition. Monitoring for such pharmacodynamic interactions is standard, with dose adjustments or discontinuation advised when threshold-lowering agents (e.g., certain antibiotics or antidepressants) are unavoidable, ensuring therapeutic safety in vulnerable populations.

Assessment Methods

Direct Measurement Techniques

Direct measurement techniques for seizure threshold involve clinical procedures that provoke and confirm s in controlled therapeutic environments to quantify the minimum stimulus required to elicit a generalized . These methods are primarily employed in settings like (ECT) to individualize dosing and optimize outcomes while minimizing risks. Due to ethical and safety concerns, such direct provocation is restricted to therapeutic contexts and is not used for routine diagnostic assessment in patients. In ECT, dose is a standard approach where electrical charge is incrementally increased from a low starting dose, such as 24 millicoulombs (mC), until a is induced and confirmed via (EEG). The process typically begins with age-adjusted minimal stimuli—often 5% of maximum device charge (approximately 25 mC) for younger adults—and doubles or escalates stepwise (e.g., to 10%, 20%, 40%) until EEG evidence of activity appears. In large cohorts of adults undergoing right unilateral brief-pulse ECT, the mean charge required to reach averages around 75 mC, though values range widely from 8 mC to over 500 mC depending on factors like placement and patient characteristics; bilateral ECT thresholds are generally higher, around 100-126 mC on average. This occurs during the first session to establish the individual , with subsequent treatments delivering 1.5-6 times that value for therapeutic efficacy. Historically, pharmacological provocation using (PTZ), a , was used in s to assess threshold through controlled intravenous infusion. The technique involved timed administration of a dilute PTZ solution (e.g., 1% w/v) at a constant rate, monitoring the latency to the onset of specific seizure behaviors or EEG changes to calculate the threshold dose in mg/kg. Employed in convulsive therapies until the mid-20th century, PTZ is no longer used in human clinical practice due to significant risks; it persists in select preclinical animal research protocols as a quantifiable proxy for excitability, with shorter latencies indicating lower thresholds. EEG is integral to confirming crossing in both ECT and pharmacological methods, capturing ictal patterns such as initial high-frequency polyspike activity followed by rhythmic spike-wave complexes. A successful is typically defined by EEG exceeding 15 seconds, with optimal therapeutic seizures lasting 30-50 seconds and exhibiting distinct phases: polyspikes (<5 seconds), regular spike-waves, and postictal suppression. Shorter s (<15 seconds) often lack adequate and are deemed inadequate, while prolonged ensures safety and verifies the absence of subclinical events.

Indirect and Research Approaches

Indirect and research approaches to estimating seizure threshold rely on surrogate measures of cortical excitability and preclinical models, avoiding direct provocation in humans. These methods provide insights into underlying neuronal vulnerability without inducing seizures, facilitating and risk stratification. (TMS) assesses cortical excitability through the motor threshold (MT), defined as the minimal stimulus intensity required to elicit a motor of at least 50 μV in the target muscle. In patients, a lower MT correlates with increased cortical hyperexcitability, inversely relating to seizure threshold, as evidenced by reduced thresholds shortly after seizures or in symptomatic cases. For instance, untreated patients with partial exhibit decreased MT compared to treated individuals or controls, indicating a state of heightened susceptibility. This non-invasive technique thus serves as a for estimating seizure proneness, particularly in monitoring treatment effects where antiepileptic drugs elevate MT. Animal models offer standardized platforms for quantifying seizure via afterdischarge threshold (ADT), the minimal current intensity eliciting an electrographic afterdischarge lasting at least 3 seconds. In the amygdala kindling model in rats, ADT is measured in microamperes (μA) through focal electrical , typically starting at 60 Hz for 2 seconds, and progressively decreases with repeated subthreshold stimulations, reflecting kindling-induced lowering of seizure . Pre-kindling ADT values often range from 200-300 μA, dropping significantly over weeks due to implantation effects or , enabling precise evaluation of efficacy in drug testing. Similarly, corneal kindling in rats involves transcorneal electrostimulation at low frequencies (e.g., 6 Hz, 0.5 ms pulses), where ADT quantifies resistance to induced limbic seizures, providing a non-invasive alternative for studying focal progression and therapeutic interventions. Biomarker proxies, such as and genetic analyses, infer seizure threshold through network-level or heritable risk indicators. Resting-state functional MRI (fMRI) examines alterations, where disrupted patterns in mode or salience networks correlate with susceptibility; for example, models using rs-fMRI matrices predict post-traumatic risk with high accuracy by identifying hyperexcitable hubs. Heightened in epileptic networks, as seen in , signifies lower threshold without stimulation. Genetic panels employ polygenic risk scores (PRS) aggregating common variants to estimate liability, with higher PRS for conferring over 3-fold increased risk, serving as a non-provocative metric across populations. These approaches collectively enable indirect threshold estimation for research and .

References

  1. [1]
    Seizure - StatPearls - NCBI Bookshelf - NIH
    The concept of a seizure threshold means that each individual exists on a seizure susceptibility continuum with many factors influencing that susceptibility.
  2. [2]
    Understanding Seizures | Is It Epilepsy?
    A person with epilepsy has a lower seizure threshold – this means they are more likely to have seizures than people without epilepsy.Who Can Get Epilepsy? · Diagnosis · Diagnosing Imitators of... · Causes of Epilepsy
  3. [3]
    What Is the Seizure Threshold, and What Can Change It? - Healthline
    Jan 26, 2023 · Your seizure threshold is one factor that influences your likelihood of having a seizure. People with epilepsy tend to have a lower seizure threshold.Factors · Triggers · Lowering seizure threshold
  4. [4]
    What is a seizure threshold - and what does it mean for you?
    Sep 27, 2023 · Put simply, a seizure threshold is the point at which the chemicals in your brain become unbalanced and you become more likely to have a seizure ...
  5. [5]
    Brief history of anti‐seizure drug development - PubMed Central
    In the late 1800s, investigators began to elicit seizure activity in animals (i.e., dogs) using electrical stimulation or chemoconvulsants derived from ...Early History Of Epilepsy... · Anticonvulsant Screening... · The Post‐modern Era
  6. [6]
    Maximal Electroshock Seizure - an overview | ScienceDirect Topics
    The first of these models, the maximal electroshock seizure (MES) test, was used by Merritt and Putnam in the 1930s to systematically screen hundreds of ...
  7. [7]
    Stress and Epilepsy: Towards Understanding of Neurobiological ...
    Nov 2, 2023 · Stress has been identified as a major contributor to human disease and is postulated to play a substantial role in epileptogenesis.<|separator|>
  8. [8]
    Sudden unexpected death in epilepsy: Respiratory mechanisms
    Compared with epilepsy patients with no known GTCS, patients having three or more GTCS per month are 15 times more likely to die from SUDEP (Hesdorffer et al., ...
  9. [9]
    The Diathesis–Epilepsy Model: How Past Events Impact the ...
    In epilepsy, seizures and comorbidities (e.g., cognitive deficits and depression) occur when specific thresholds are crossed. These thresholds depend on the ...
  10. [10]
    Effects of psychotropic drugs on seizure threshold - PubMed
    Apart from drug-related factors, seizure precipitation during psychotropic drug medication is greatly influenced by the individual's inherited seizure threshold ...
  11. [11]
    Glutamatergic Mechanisms Associated with Seizures and Epilepsy
    Seizures elevate extracellular glutamate—the main excitatory neurotransmitter of the brain—which leads to aberrant neuronal signaling and connectivity.
  12. [12]
    Basic Mechanisms Underlying Seizures and Epilepsy - NCBI
    A seizure (from the Latin sacire—to take possession of) is the clinical manifestation of an abnormal, excessive, hypersynchronous discharge of a population ...
  13. [13]
    Brain concentrations of glutamate and GABA in human epilepsy
    Excess glutamate and/or inadequate GABA can lead to overexcitation in the CNS, leading to seizure occurrence [6,7,14]. Potential dysregulation in glutamatergic ...
  14. [14]
    Role of Sodium Channels in Epilepsy - PMC - PubMed Central
    Voltage-gated sodium channels (VGSCs) play central roles in epilepsy. More than 700 mutations in genes for VGSCs have been identified in patients with epilepsy.
  15. [15]
    Sodium channel mutations in epilepsy and other neurological ... - JCI
    Aug 1, 2005 · Impaired inactivation of sodium channel α subunits is the likely mechanism relating β1 mutations to neuronal hyperexcitability in epilepsy.
  16. [16]
    Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review
    There are several known causes for epilepsy; one of them is the malfunction of ion channels, resulting from mutations. Voltage-gated sodium channels (NaV) play ...Abstract · Introduction · NaV Mutations · Conclusion and Future...
  17. [17]
    Plasticity of Hippocampal Excitatory-Inhibitory Balance: Missing the ...
    Long-term plasticity of glutamatergic and GABAergic transmission occurs in a concerted manner, finely adjusting the excitatory-inhibitory (E/I) balance.
  18. [18]
    Interactions Between Epilepsy and Plasticity - MDPI
    Through different studies, it has been shown that short- and long-term synaptic plasticity responses may change substantially in the hippocampus and cerebral ...
  19. [19]
    Neurons | Organismal Biology
    The threshold potential is usually about -55 mV, compared to the resting potential of about -70 mV. If the threshold potential is reached, then an action ...
  20. [20]
    Local Generation of Fast Ripples in Epileptic Brain
    Mar 1, 2002 · Aperiodic high-frequency oscillations (>100 Hz) reflect a short-term synchronization of neuronal electrical activity.
  21. [21]
    Epileptic high-frequency network activity in a model of non-lesional ...
    Recordings from the hippocampi of freely-moving epileptic rats revealed high-frequency activity (>100 Hz), including fast ripples. High-frequency activity was ...
  22. [22]
    [PDF] Hyper-Synchronization, De-Synchronization, Synchronization and ...
    At a larger spatial scale, epileptic seizures are usually described as a state of "hypersynchrony" encompassing extended cortical areas. Synchronization and ...
  23. [23]
    Thalamus and focal to bilateral seizures - Neurology.org
    Converging evidence indicates that subcortical nuclei, particularly the thalamus, may be involved in the propagation of temporal lobe seizures. Resting-state ...
  24. [24]
    Thalamocortical circuits in generalized epilepsy - PubMed Central
    The thalamus, with widespread connections throughout the brain, plays a critical role in generalized epilepsy.Missing: seminal | Show results with:seminal
  25. [25]
    Neocortical and Thalamic Spread of Amygdala Kindled Seizures
    Feb 2, 2007 · Conclusions: We found evidence for increased connectivity between the amygdala and frontal cortex both during seizures and in the interictal ...<|control11|><|separator|>
  26. [26]
    Subcortical Structures and Pathways Involved in Convulsive Seizure ...
    Limbic motor seizures depend on forebrain structures for their initiation and propagation ... role in conjunction with hippocampus, amygdala, substantia ...
  27. [27]
    Long-lasting hyperpolarization underlies seizure reduction by low ...
    Like the GABAB IPSP, the slow afterhyperpolarization (sAHP) limits the firing frequency of neurons and is responsible for generating spike-frequency adaptation, ...Seizure Generation · Glial Cells Do Not Exhibit... · Figure 7. Gaba/sahp...Missing: feedback seminal
  28. [28]
    Modulation of seizure-like events by the small conductance and ATP ...
    These channels can underlie the post-burst afterhyperpolarization and be upregulated during seizures, providing negative feedback during epileptic activity.Missing: seminal | Show results with:seminal
  29. [29]
    Proposal for best practice in the use of video-EEG when ... - NIH
    Assessment of the pre-ictal EEG is important because non-epileptic events may occur as a dissociative or conversion response triggered by an epileptic seizure ( ...
  30. [30]
    Effects of carbamazepine, clonazepam, and phenytoin on seizure ...
    All three drugs were found to be effective in increasing the seizure threshold with greater effects being produced in the cortex than in the amygdala.
  31. [31]
    Modulation of seizure threshold by vagus nerve stimulation in an ...
    This study investigates whether VNS modulates cortical excitability by determining the threshold for provoking focal motor seizures by cortical electrical ...
  32. [32]
    Seizure Triggers | Epilepsy Foundation
    ### Summary on Avoiding Seizure Triggers to Reduce Seizure Frequency
  33. [33]
    A RETROSPECTIVE ANALYSIS OF SEIZURE FREQUENCY - NIH
    Feb 15, 2012 · ... seizure threshold). Reflex epilepsy on the other hand is ... Health-related quality of life in adolescents with well-controlled epilepsy.
  34. [34]
    Clinical predictors of seizure threshold in electroconvulsive therapy
    This study explores clinical factors predicting initial ST (IST) and levels of ST during the ECT course.
  35. [35]
    Stimulus dose titration for electroconvulsive therapy - Chung - 2001
    Dec 21, 2001 · The starting stimulus dose of our titration protocol was adjusted on the basis of gender (women, 48 mC; men, 80 mC). This approach is modeled ...
  36. [36]
    Seizure Threshold in Electroconvulsive Therapy: Effects of Sex, Age ...
    Sex, age, electrode placement, and the cumulative number of treatments were each associated with seizure threshold. Bilateral ECT had both a higher initial ...
  37. [37]
    Effects of Stimulus Intensity and Electrode Placement on the Efficacy ...
    Mar 25, 1993 · The increase in seizure threshold during electroconvulsive therapy was greater with low-dose bilateral therapy than with low-dose unilateral ...<|control11|><|separator|>
  38. [38]
    Seizure Medications - StatPearls - NCBI Bookshelf - NIH
    Other mechanisms through which AEDs act are by enhancing gamma-aminobutyric acid (GABA)-A receptors (phenobarbital, benzodiazepines), blocking N-methyl-D- ...
  39. [39]
    Antibiotic-induced epileptic seizures: mechanisms of action and ...
    Gamma-aminobutyric acid (GABA) receptor antagonism is a common mechanism shared by penicillins, cephalosporins, imipenem, and fluoroquinolones [2,3].
  40. [40]
    Convulsant and Subconvulsant Doses of Norfloxacin in the ...
    Fluoroquinolones are antibiotics with central excitatory side effects. These adverse effects presumably result from inhibition of γ-aminobutyric acid (GABA) ...Missing: examples | Show results with:examples
  41. [41]
    (PDF) The maximal electroshock seizure (MES) model in the ...
    Aug 7, 2025 · The MES test is one of the most widely used pre-clinical models for assessing the efficacy of AEDs, particularly against generalized tonic- ...
  42. [42]
    The maximal electroshock seizure (MES) model in the preclinical ...
    The purpose of this paper is to describe the most important aspects to take into account when performing the maximal electroshock seizure (MES) test.Missing: ED50 | Show results with:ED50
  43. [43]
    Using antidepressants for depression in people with epilepsy – SPS
    May 14, 2021 · Tricyclic antidepressants (particularly amitriptyline and clomipramine) should be avoided as they lower the seizure threshold and are deemed the ...<|control11|><|separator|>
  44. [44]
    Tramadol: Seizures, Serotonin Syndrome, and Coadministered ...
    Of these various interactions, tramadol has the potential to trigger two dramatic events—seizures and serotonin syndrome. These may develop during tramadol ...Missing: threshold | Show results with:threshold
  45. [45]
    Tramadol Extended-Release for the Management of Pain due to ...
    Tramadol should be avoided in patients with a history of epilepsy or with a recognized risk of seizure (head trauma, metabolic disorder, alcohol abuse, CNS ...2.1. Mechanism Of Action · 4. Drug Interactions · 6. Extended-Release...
  46. [46]
    Stimulus Titration and ECT Dosing - The Journal of ECT
    With the dose-titration technique, dosing at 2.5–6 times seizure threshold was suggested for UL ECT versus 1.5–2.5 times threshold for BL ECT. Fixed dosing ...
  47. [47]
    Seizure Threshold in a Large Sample: Implications for Stimulus ...
    We sought to examine the relationship of seizure threshold (ST) to age and other demographic characteristics in a large sample where ST was determined by ...Missing: earliest | Show results with:earliest
  48. [48]
    Charge required to induce a seizure during initial dose titration ...
    This study quantifies the charge required to induce a seizure using right unilateral brief pulse (RUL-BP) ECT in a large retrospective cohort.
  49. [49]
    Evaluation of the pentylenetetrazole seizure threshold test in ...
    The threshold for PTZ-induced seizures was determined by timed intravenous (i.v.) infusion of a 1% solution of PTZ via flexible tubing placed into the tail vein ...
  50. [50]
    [PDF] EEG Interpretation and Seizure Efficacy measures | RANZCP
    Galvez and Waite showed that seizure threshold (as shown by re-titration) rises in about 60% of patients having RUL UB ECT by session 7.Missing: criteria | Show results with:criteria
  51. [51]
    [PDF] The Current Status of Seizure Duration in the Practice of ...
    Jun 5, 1996 · Seizures of less than. 15 seconds are associated with postictal autonomic com- plications and poor clinical results (17,18), but there is little.
  52. [52]
    Evoked motor response thresholds during transcranial magnetic ...
    The shorter the interval between a seizure and TMS, the smaller the evoked motor response threshold. The low threshold seen in patients with symptomatic ...
  53. [53]
    Lamotrigine and retigabine increase motor threshold in transcranial ...
    In this study, we found that the antiepileptic drugs, lamotrigine (10 mg/kg) and retigabine (5 mg/kg), significantly increased the MT in rats using TMS.
  54. [54]
    Afterdischarge threshold reduction in the kindling model of epilepsy
    Pre-kindling ADT's were highest 1 week after implantation, lower at 2 weeks, and lowest at 4 weeks. This drop in non-stimulated thresholds had largely ...
  55. [55]
    Seizures elicited by transcorneal 6 Hz stimulation in developing rats
    Jan 3, 2025 · The data extend the use of the rat 6 Hz model to immature animals and may be useful as a model of pediatric temporal lobe seizures.
  56. [56]
    A Machine Learning Model to Predict Seizure Susceptibility from ...
    A Machine Learning Model to Predict Seizure Susceptibility from Resting-State fMRI Connectivity. Abstract: Traumatic brain injury (TBI) is a leading cause of ...
  57. [57]
    Resting state functional connectivity patterns associated with ... - NIH
    Resting state functional magnetic resonance imaging (Rs-fMRI) provides a powerful means to evaluate neural network connectivity and its alterations in epilepsy.
  58. [58]
    Polygenic risk scores as a marker for epilepsy risk across lifetime ...
    Jul 25, 2024 · We found that a high genetic generalized epilepsy PRS (PRS GGE ) increased risk for genetic generalized epilepsy (GGE) (hazard ratio [HR] 1.73 per PRS GGE ...